Operativer Cashflow in Höhe von 322 Millionen R$, ein Rekord für das dritte Quartal des Unternehmens SÃO PAULO, 17. November 2023 /PRNewswire/ — Oncoclínicas & Co. (B3: ONCO3) meldete für das dritte Quartal 2023 einen Anstieg der Bruttoeinnahmen um 23,4 % auf 1,5 Milliarden R$, ein…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.